17 lose licence to make obesity drug Livemint, India - Nov 24, 2008 ... according to data from research firm ORG IMS. Despite all the hype, rimonabant did not catch the fancy of many doctors in the country. ...PINK:SNYNF - SNY
Eat Your Statins Forbes, NY - Nov 16, 2008 The first statin drug was derived from a fungal broth by Akira Endo, a scientist at the Japanese drug firm Sankyo, in the 1970s. Merck's (nyse: MRK - news ...
AFL rules Cousins can play, conditions apply The Canberra Times, Australia - Nov 18, 2008 Sheedy also said any club considering drafting Cousins shouldn't be put off by the hype and potential distractions his recruitment would cause. ...
Merck's 2008: The Year That Wasn't Trading Markets (press release), CA - Nov 19, 2008 At times, the hype surrounding combination pills seems to run far ahead of their clinical benefit, igniting a firestorm of controversy. ...MRK
Hillsong: Exorcism in the suburbs LIVENEWS.com.au, Australia - Nov 25, 2008 Having been to one of their ?HSC Hype? study camps for Year 12 students, where they tried to brow-beat kids into becoming born again and stories about ...
Separating the green from the rest San Jose Mercury News, USA - Nov 7, 2008 In many cases, experts say, it's a lot of hype, or what they call "greenwashing." "The word 'green' doesn't mean anything," said Susan Lewicki, ...
Television movies for the week of Nov. 30 Pittsburgh Post Gazette, PA - Nov 29, 2008 Louis Gossett Jr. Four ex-fighter pilots fly refurbished World War II planes against a drug lord in the jungles of South America. (R) (2:00) WGN: Sat. ...
Top 10 worst chief executives PC Authority, Australia - Nov 24, 2008 The company's meteoric rise, huge marketing hype, and subsequent collapse became the sort of thing business professors write textbooks about. ...
Beaker Fuel Truth about Trade & Technology, IA - Nov 7, 2008 Living up to the hype will require some serious feats of industrial engineering. Making ethanol from sugar is a straightforward fermentation. ...
Source: Google News
Recent News and Articles on the Keywords: drug + firms + diseases Related to the article below (Last Update: 8/5/2008)
End of an era ArabianBusiness.com, United Arab Emirates - When it comes to cutting drug costs, Indian pharma firms lead the field. Experts agree that large domestic players like Dr Reddy's Laboratories and Ranbaxy ...
Extra funds for disease research BBC News, UK - Scientists in Dundee have been given ?10.8m pounds to continue developing new drugs for global diseases. The work is being carried out in the Division of ...
NEW AMERICA Investor's Business Daily (subscription) - The company manages clinical trials for drug and biotech firms, and its clients are clamoring, if not desperate, for its services. Drug firms are ...
Bothell biotech laying off 30 percent of employees Seattle Times, United States - Most of these programs focus on cancer, metabolic disorders and inflammatory diseases. There's also a research program for an influenza drug, ...
Analysts forecast boom for heart disease drugs Business Daily Africa, Kenya - Jul 15, 2008 The price undercutting is the result of the increased number of drug firms that are opening shop in Kenya as the firms position themselves to grow their ...
GENOMICS: Drug Firms to Create Public Database of Genetic Mutations - E Marshall - Science, 1999 - sciencemag.org ... tools, making it easier to trace inherited disease risks and ... enable them to develop
and sell drugs more effectively ... the half-dozen or so biotech firms that have ...
Drug firms hype disease as sales ploy, industry chief claims - R Moynihan - BMJ: British Medical Journal, 2002 - pubmedcentral.nih.gov ... Copyright ? 2002, BMJ. Drugfirms hype disease as sales ploy, industry chief claims.
Ray Moynihan Sydney. This article has been cited by other articles in PMC. ...
Groups, the Media, Agency Waiting Costs, and FDA Drug Approval - DP Carpenter - American Journal of Political Science, 2002 - JSTOR ... Patients want a drug for their disease, and firms that profit from drug
sales want entry into potentially lucrative markets. To ...
Alzheimer's disease: A firm base for drug development - B De Strooper, G K?nig - Nature, 1999 - nature.com ... Nature 402, 471-472 (2 December 1999) | doi :10.1038/44973. Alzheimer's disease:
A firm base for drug development. Bart De Strooper and Gerhard K?nig. ...
Measuring competence? Exploring firm effects in pharmaceutical research - R Henderson, I Cockburn - Strategic Management Journal, 1994 - JSTOR ... 2 Thus we hypothesize: Hypothesis 1: Drug discovery productivity ... The second dimension
along which firms may be able ... about the etiology of many diseases and the ...
[PDF]Increasing R&D incentives for neglected diseases: lessons from the Orphan Drug Act - H Grabowski - International Public Goods, and Transfer of Technology Under …, 2005 - econ.duke.edu ... undertaking development of a drug for diseases of poverty. Under the FDAMA Act,
US firms can obtain six months of added market exclusivity on approved ...
The use of single-nucleotide polymorphism maps in pharmacogenomics - JJ McCarthy, R Hilfiker, AG Solvias, S Basel - Nature Biotechnology, 2000 - nature.com ... Davidson, S. Incyte SNPs up Hexagen for new firm. ... a molecular basis for individualized drug therapy: the ... future of genetic studies of complex human diseases. ...
Source: Google Scholar
Drug firms 'hype up diseases to boost sales'
Drug companies are inventing diseases to sell more of their products, it has been claimed. Scientists have accused major pharmaceutical firms of "medicalising" problems like high cholesterol or the symptoms of the menopause in a bid to increase profits.
Experts from around the world will meet in Australia today to discuss what they have labelled "disease-mongering".
The group, which includes experts from Britain, will gather in Newcastle, New South Wales, where researchers have been examining the issue. David Henry and Ray Moynihan, of Newcastle University, claim the industry is exaggerating conditions and turning them into something more serious.
Female sexual dysfunction, attention deficit hyperactivity disorder (ADHD) and "restless legs" syndrome have all been promoted by the pharmaceutical industry in the hope of selling more drugs, they say.
High cholesterol and osteoporosis-are being described as diseases in their own right, the researchers claim, turning healthy people into patients. In turn, this wastes precious resources and can cause medically-induced harm.
Drugs prescribed for 'shyness'
Even shyness is routinely presented as a "social anxiety disorder" resulting in the person being prescribed anti-depressants.
In the case of male sexual disfunction, the researchers say, Viagra is promoted as not only a genuine treatment for erectile dysfunction but also a lifestyle improver. The two men make their claims in the Public Library of Science Medicine journal.
They accuse drug companies of funding disease-awareness campaigns through the media that are more about selling drugs than helping or educating the public.
"Like the marketing strategies that drive it, disease-mongering poses a global challenge to those interested in public health, demanding in turn a global response," they say.
Mr Moynihan and Mr Henry say that, in their view, disease mongering is the selling of sickness that widens the boundaries of illness and grows markets for those who sell and deliver treatments.
"It is exemplified most explicitly by many pharmaceutical industryfunded disease-awareness campaigns, more often designed to sell drugs than to illuminate or to inform or educate about the prevention of illness or the maintenance of health," they add. Conference organisers say they will try to draw a line between "market-driven exercises and legitimate disease-awareness programmes". 'Miracle solutions'
Drugs companies hit back last night. GlaxoSmithKline said: "We pride ourselves in providing miracle solutions to the health care needs of people every day.
"We utterly refute any suggestion that we would in any way hype or overplay the very real needs of patients that are treated all over the world.
"One of the exciting things about medical science is that we are finding new solutions to ailments or problems people have, and this is something good we can offer." Pfizer, which makes Viagra, said: "We would refute accusations that the pharmaceutical industry is medicalising society. Treatments that can make serious and potentially life-threatening conditions better should surely be welcomed.
"Pfizer would only promote prescription medicines to health care professionals, and only in line with what licensing bodies have outlined, for them to use their clinical judgment."
52 people have commented on this story.
Here's a sample of the latest comments published.
It's quite obvious that the drug companies are not just promoting these drugs only to health care professionals as Pfizer is quoted as saying in the article. Their commercials are all over television all day and all night. They are going directly to the consumer and the message is to go and see your doctor about getting this or that drug, and to ask for it by name, or ask for a free trial.
Clearly, profits are the driver here, and not is what is best for everyone's health.
I for one am glad to see that a dialog is being opened on this subject. The drug companies are out of control.
- John Hastings, Philidelphia, PA
I also think they sell their hype to Governments. I'm sick of hearing about the bird flu.
- Daryl, Seattle, WA
This is old news. We've known big pharma has been inventing "diseases" for a long time now. Read Germaine Greer on how medicalized menopause has become in her great book, "The Change".
